Disodium Pamidronate Overview Categories 18 Hormones and other endocrine drugs and contraceptives18.14 Drugs affecting bone metabolism Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Dantron Manufacturers of Dantron Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Dantron's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 30 mg30 (30)24 hourlyIVFor paget disease: administered as a 4-hour infusion on 3 consecutive days for a total dose of 90 mg.60 to 90 mg75 (75)As recommended.IVModerate hypercalcemia: Given as a SINGLE-DOSE, intravenous infusion over 2 to 24 hours. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Dantron is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Dantron is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Dantron Back to top Manufacturers of Disodium Pamidronate in Pakistan Back to top Previous Drug Generic - Next Drug Generic
Disodium Pamidronate Overview Categories 18 Hormones and other endocrine drugs and contraceptives18.14 Drugs affecting bone metabolism Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Dantron Manufacturers of Dantron Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Dantron's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 30 mg30 (30)24 hourlyIVFor paget disease: administered as a 4-hour infusion on 3 consecutive days for a total dose of 90 mg.60 to 90 mg75 (75)As recommended.IVModerate hypercalcemia: Given as a SINGLE-DOSE, intravenous infusion over 2 to 24 hours. Paedriatic Dosage (20kg) No data regarding the Paedriatic dosage details of Dantron is available. Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Dantron is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Dantron Back to top Manufacturers of Disodium Pamidronate in Pakistan Back to top Previous Drug Generic - Next Drug Generic